The molecular complexity of cancer demands a systems-level approach that moves beyond single-omics analyses.
Next-generation sequencing (NGS) has revolutionized minimal residual disease (MRD) monitoring in hematologic malignancies, offering unprecedented sensitivity down to 10^-6 and the unique ability to track clonal evolution.
Next-generation sequencing (NGS) of Formalin-Fixed Paraffin-Embedded (FFPE) samples unlocks vast potential for cancer research and clinical diagnostics, yet the path to high-quality data is fraught with technical challenges.
This article provides a comprehensive overview of RNA sequencing (RNA-seq) for detecting clinically relevant gene fusions in cancer.
This article provides a comprehensive overview of the principles and clinical applications of Next-Generation Sequencing (NGS) in oncology, covering both DNA and RNA sequencing.
Next-generation sequencing (NGS) has fundamentally transformed our understanding and investigation of cancer heterogeneity, moving beyond organ-based classification to a molecular-level understanding of tumor evolution, resistance, and metastasis.
This article provides a comprehensive examination of Tumor Mutational Burden (TMB) as a predictive biomarker for immunotherapy response, focusing on Next-Generation Sequencing (NGS) methodologies.
This article provides a comprehensive overview of how Next-Generation Sequencing (NGS) is revolutionizing biomarker discovery in immuno-oncology.
This article provides a comprehensive overview of the transformative role of liquid biopsy and circulating tumor DNA (ctDNA) analysis in modern oncology.
Next-generation sequencing (NGS) has fundamentally transformed precision oncology by enabling comprehensive genomic profiling of tumors, thus guiding diagnosis, prognostication, and personalized treatment selection.